Today's Daily Dose brings you news about BioCryst Pharma's upcoming regulatory event, Brickell Biotech clearing legal uncertainty related to its lead asset, Bellerophon's phase IIb data of INOPulse, and progress on Lurbinectedin NDA.
from RTT - Biotech https://ift.tt/37FkViT
via IFTTT
No comments:
Post a Comment